Feng Zheng from East Brunswick, NJ, age 42

Lawyers & Attorneys

Feng Zheng

Name / Title

Company / Classification

Phones & Addresses

Feng Zheng
Principal

Rainbow Ny Trading Corp
Whol Nondurable Goods

8014 54 Ave, Flushing, NY 11373

Feng Qing Zheng
Principal

SOGA WIRELESS INC
Radiotelephone Communication

6608 50 Ave Flr 2, Woodside, NY 11377
6608 50 Ave, Flushing, NY 11377

Feng Zheng

ZYW HONG KONG INC

Feng Zheng

C & Z GRAND BUFFET INC

Feng Zheng

SAKURA II INC

Feng Zheng

GOLDEN DEALS TRADING INC

133-14 39 Ave 1F, Flushing, NY 11354
133-14 39 Ave, Flushing, NY 11354
123-14 39 Ave, Flushing, NY 11354

Feng Sheng Zheng
Chief Executive Officer

China Herbal Company Inc
Ret Herbs

97 E Broadway, New York, NY 10002

Feng Ying Zheng

88 CHINESE EXPRESS LLC

167 Highland Ave, Waterbury, CT 06708
2 Mott St, New York, NY 10013
3 Possum Dr, New Fairfield, CT 06812

Resumes

Feng June Zheng

view source

Location:

Brooklyn, NY

Industry:

Restaurants

Work:

Jasmine Buffet 2010 - 2013
Manager

Feng Zheng

view source

Work:

Lafargeholcim 2009 - 2010
Hse

Skills:

Sales
Operations
Cement

Feng Zheng

view source

Picker

view source

Location:

East Brunswick, NJ

Work:

Amazon Fulfillment Centre
Picker

Feng Zheng

view source

Feng Zheng

view source

Feng Zheng

view source

Feng Zheng

view source

Location:

United States

Us Patents

Inhibition Of Tnf-Alpha Induced Activation Of Nfkb By Pentosan Polysulfate
view source
US Patent:

20130143837, Jun 6, 2013
Filed:

Jan 14, 2011
Appl. No.:

13/522441
Inventors:

Gary E. Striker - New York NY, US
Helen Vlassara - New York NY, US
Feng Zheng - Middle Village NY, US
Assignee:

MOUNT SINAI SCHOOL OF MEDICINE - New York NY
International Classification:

A61K 31/737
C12Q 1/02
US Classification:

514 54, 435184, 435 612, 506 10
Abstract:

Oral pentosan polysulfate (PPS) compositions treat diseases such as diabetes, inflammation, atherosclerosis. The compositions are also effective in reducing matrix metalloproteinases (MMPs).

Inhibition Of Tnf-Alpha Induced Activation Of Nfkb By Pentosan Polysulfate
view source
US Patent:

20150141369, May 21, 2015
Filed:

Sep 19, 2014
Appl. No.:

14/490916
Inventors:

- New York NY, US
Helen Vlassara - New York NY, US
Feng Zheng - Middle Village NY, US
International Classification:

A61K 31/737
US Classification:

514 54
Abstract:

Oral pentosan polysulfate (PPS) compositions treat diseases such as diabetes, inflammation, atherosclerosis. The compositions are also effective in reducing matrix metalloproteinases (MMPs).